These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36891994)

  • 41. In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents.
    Abuelizz HA; El-Dib RA; Marzouk M; Al-Salahi R
    Microb Pathog; 2018 Apr; 117():60-67. PubMed ID: 29432912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The structure - Activity correlation in the family of dicationic imidazolium surfactants: Antimicrobial properties and cytotoxic effect.
    Voloshina AD; Gumerova SK; Sapunova АS; Kulik NV; Mirgorodskaya AB; Kotenko AA; Prokopyeva TM; Mikhailov VA; Zakharova LY; Sinyashin OG
    Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129728. PubMed ID: 32898623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates.
    Swain SS; Paidesetty SK; Padhy RN
    Biomed Pharmacother; 2017 Apr; 88():181-193. PubMed ID: 28107695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.
    Jin J; Cui J; Chaudhary AS; Hsieh YH; Damera K; Zhang H; Yang H; Wang B; Tai PC
    Bioorg Med Chem; 2015 Nov; 23(21):7061-8. PubMed ID: 26432604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibacterial, anti-biofilm activity and mechanism of action of pancreatin doped zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus.
    Banerjee S; Vishakha K; Das S; Dutta M; Mukherjee D; Mondal J; Mondal S; Ganguli A
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110921. PubMed ID: 32172163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of Antibiotic Activity by 1,8-Naphthyridine Derivatives against Multi-Resistant Bacterial Strains.
    Araújo-Neto JB; Silva MMCD; Oliveira-Tintino CDM; Begnini IM; Rebelo RA; Silva LED; Mireski SL; Nasato MC; Krautler MIL; Ribeiro-Filho J; Siyadatpanah A; Wilairatana P; Coutinho HDM; Tintino SR
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WYBQ-4: a New Bactericidal Agent against Methicillin-Resistant Staphylococcus aureus.
    Guan S; Yu H; Xiang H; Wang L; Liu J; Wu A; Zheng J; Dong H; Wang L; Wang D
    Microbiol Spectr; 2022 Oct; 10(5):e0054722. PubMed ID: 36098533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
    Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
    Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel antimicrobial polymer efficiently treats multidrug-resistant MRSA-induced bloodstream infection.
    Chen X; Lou W; Liu J; Ding B; Fan W; Hong J
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31548363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Gerstel J; Turner T; Ruiz G; Wise J; Stein A; Jones G; Morin T; Pinazza T; Sukhorukov E; Clark D; Steen T; Wright B; Langland J
    Phytother Res; 2018 Dec; 32(12):2577-2585. PubMed ID: 30251279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tackling Microbial Resistance with Isatin-Decorated Thiazole Derivatives: Design, Synthesis, and in vitro Evaluation of Antimicrobial and Antibiofilm Activity.
    Kassab RM; Al-Hussain SA; Elleboudy NS; Albohy A; Zaki MEA; Abouzid KAM; Muhammad ZA
    Drug Des Devel Ther; 2022; 16():2817-2832. PubMed ID: 36046334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological evaluation of some new N-(2,6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents.
    Ghorab MM; Alsaid MS; El-Gaby MSA; Safwat NA; Elaasser MM; Soliman AM
    Eur J Med Chem; 2016 Nov; 124():299-310. PubMed ID: 27597407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial and Antibiofilm Activities of Novel Cyclic Peptides against Methicillin-Resistant
    Wei G; He Y
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products; investigation of antibacterial and anti-biofilm activity against antibiotic resistant clinical isolates.
    Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
    Bioorg Med Chem; 2018 Sep; 26(17):4930-4941. PubMed ID: 30185388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
    Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
    Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
    PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).
    Ciandrini E; Morroni G; Arzeni D; Kamysz W; Neubauer D; Kamysz E; Cirioni O; Brescini L; Baffone W; Campana R
    Curr Top Med Chem; 2018; 18(24):2116-2126. PubMed ID: 30345920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.